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ABSTRACT 
Lung cancer is one of the most lethal solid 
cancers with a high propensity for brain 
metastasis. Scutellaria spp., a widely used herb in 
Chinese and Native American medicine, can 
inhibit the growth of various tumor types, 
including brain tumors. This study 
mechanistically evaluated the efficacy of 
Scutellaria ocmulgee leaf (SocL) extract against 
the proliferation and metastatic potential of 
brain-metastatic lung cancer cells. Two non-small 
cell lung cancer (NSCLC) cell lines and two 
patient-derived brain-metastatic NSCLC cells 
were used in this study. The proliferation/survival 
of NSCLC cells was examined via WST assay, 
while induction of apoptosis was evaluated via 
flow cytometry. In vivo and in vitro metastatic 
potential of NSCLC cells were evaluated using a 
zebrafish model and a wound-healing assay, 
respectively. Intracellular signaling was queried 
by western blot analysis. SocL extract and the 
constituent flavonoid wogonin dose-dependently 
inhibited the proliferation of NSCLC cells, with 
50% inhibition of proliferation at approximately 
150 μg/ml. SocL extract dose-dependently 
enhanced the frequency of early apoptotic cells. 
There was a dose-dependent inhibition of Akt and 
p44/42, while the phosphorylation of p38 was 
dose-dependently enhanced by SocL extract. 
SocL-mediated inhibition of proliferation and 
induction of apoptosis was significantly reversed 
by specific inhibitors of p38 signaling. Finally, the 
migration/metastatic potential of NSCLC cells 
was dose-dependently inhibited by SocL extract 
in vitro as well as in the zebrafish model, which 
involved modulation of MMP2 expression. Our 
studies indicate that SocL extract could be a 
potential candidate for developing neoadjuvant 
therapy for metastatic NSCLC. 
Abbreviations: Akt, protein kinase B; Bcl-2, B-cell 
lymphoma 2; Bcl-xL, B-cell lymphoma-extra large; 
DMEM, Dulbecco's Modified Eagle Medium; ERK, 
extracellular signal-related kinases; FBS, fetal 
bovine serum; GSK, glycogen synthase kinase; HRP, 
horseradish peroxidase enzyme; IACUC, 
Institutional Animal Care and Use Committee; ICIs, 
immune checkpoint inhibitors; MAPK, mitogen-
activated protein kinases; MMPs, Matrix 
metallopeptidases; NSCLC, non-small cell lung 
cancer; PBS, phosphate-buffered saline; PFA, 
paraformaldehyde; PVDF, polyvinylidene 
difluoride; SocL, Scutellaria ocmulgee leaves; TCM, 
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traditional Chinese medicine; TGF-β1, transforming 
growth factor beta 1; WST, Water-soluble 
tetrazolium salt 
INTRODUCTION 
Lung cancer is one of the most prevalent and 
lethal cancers with an estimated 228,150 new cases 
with an estimated mortality of 142,000 in the U.S. in 
2019 (Society, 2019). Metastasis is a major concern 
with advanced forms of lung cancer, with the brain 
as a frequent site of migration (Tamura et al., 2015). 
Non-small cell lung cancer (NSCLC) comprises 
approximately 85% of lung cancers. Sub-types of 
NSCLC include adenocarcinoma, squamous cell 
carcinoma, and large cell carcinoma (American 
Cancer Society, 2019). Adenocarcinoma is the most 
prevalent form of metastatic lung cancer with an 
overall 5-year survival rate of 19.4% in treated 
patients, and 2% in those who wish to forgo 
treatment. Immunotherapy, specifically the use of 
immune checkpoint inhibitors (ICIs), has 
significantly improved clinical outcomes in patients 
with lung adenocarcinoma. However, most lung 
cancer patients do not respond to ICIs or develop 
resistance after the initial response (Milovanovic et 
al., 2017; Institute, 2019). Therefore, it is necessary 
to develop novel forms of neoadjuvant therapeutics 
for this deadly disease. 
Previous research from our lab has shown that the 
leaf extract of Scutellaria ocmulgee (SocL) can 
inhibit the growth of various tumor types, including 
malignant gliomas, via direct tumor-cytotoxic 
activity (Parajuli et al., 2009; Parajuli et al., 2011) as 
well as via modulation of stromal immune functions 
(Dandawate et al., 2012). In this study, we 
determined inhibition of the brain-metastatic 
potential of lung cancer cells by SocL extract in vitro 
as well as in vivo using a zebrafish model. Some 
underlying mechanisms in relation to modulation of 
p38 MAPK signaling were also examined.  
MATERIALS AND METHODS 
Scutellaria ocmulgee leaf (SocL) extract and 
wogonin. Cultivation of S. ocmulgee plants, 
harvesting of leaves, and extraction were performed 
as per the protocol described earlier (Parajuli et al., 
2009). Plants were cultivated in the greenhouse 
conditions to minimize batch-to-batch variation. 
New plants were established through root divisions 
in March that reach maturity in May and leaves were 
harvested before the onset of flowering. The leaves 
were dried with constant turning in shed at room 
temperature to remove about 80% moisture. The 
dried leaves were then crushed and processed for 
methanol:water (1:1) extraction using an ASE 
apparatus (Dionex Corporation, Sunnyvale, CA), as 
described earlier (Parajuli et al., 2009). The extract 
has been characterized and tested for anti-cancer 
activity against U87-MG glioma cell line and 
wogonin was used as an internal standard as 
described previously (Parajuli et al., 2009; Parajuli et 
al., 2011). The flavonoid wogonin (purity 98%) was 
purchased from Sigma Chemical Co. (St. Louis, 
MO). Wogonin was reconstituted in dimethyl 
sulfoxide (DMSO) and then diluted in appropriate 
media, as indicated. The final concentration of 
DMSO in the media for all experiments were <0.1%. 
Therefore, 0.1% DMSO was used in the Control 
media for all experiments. 
Lung cancer cells. Two standardized metastatic 
non-small cell lung cancer lines, A-549 and NCI-
H358 (obtained from American Type, Tissue 
Culture, Manassas, VA) and two patient-derived 
brain metastatic lung AC cells, 18-032 and 18-033 
were used in this study (see Supplementary Material 
for redacted pathological reports). Tumor tissues 
were obtained from patients with histologically-
confirmed brain-metastatic lung cancer immediately 
after surgical resection, under a protocol approved by 
the Institutional Review Board at Wayne State 
University (IRB # 111610MP2E). Dissociation and 
culture of patient-derived tumor cells were 
performed following a previously described method 
(Michelhaugh et al., 2015; Parajuli et al., 2016). The 
tumor cells were cultured in DMEM/F12 containing 
10% FBS. 
Proliferation assay. A previously described 
method was followed (Parajuli et al., 2016) with 
some modifications. Briefly, cells were seeded in 96-
well flat-bottom plates (2 x104 cells/well) and 
cultured in the presence of varying doses of SocL and 
specific cell signaling inhibitors, as indicated. After 
incubation at 37°C for 3 days, cell viability was 
evaluated using the WST-1 assay kit (Clonetech 
Laboratories, Mountain View, CA) as per the 
manufacturer’s protocol. Cell viability/proliferation 
was expressed as a percent of control (cells cultured 
with medium alone). 
Apoptosis assay. A previously described method 
was followed (Parajuli et al., 2009) with some 
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modifications. Briefly, cells were seeded in 6-well 
flat-bottom plates (5 x105 cells/well) and cultured in 
the presence of varying doses of SocL and specific 
cell signaling inhibitors, as indicated. After 
incubation at 37°C for 48 h, the cells were stained 
with Annexin V-FITC and PI, then analyzed via flow 
cytometry.  
Intracellular signaling analysis via western blot 
assay. A previously described method was followed 
(Dandawate et al., 2012). Briefly, lung cancer cells 
were seeded in 6- or 12-well plates and cultured in 
the presence of varying doses of SocL, as indicated. 
After incubation at 37°C for 48 h, cells were lysed, 
20–30 µg aliquots of total protein were 
electrophoresed, transferred onto a polyvinylidene 
difluoride (PVDF) membrane, and probed with 
specific antibodies (Table 1S, under Supporting 
Information section). Detection of HRP-conjugated 
secondary Abs was performed using SuperSignal 
(Pierce, Rockford, IL) and chemiluminescence was 
recorded using an Omega imaging system (UltraLum 
Inc., Claremont, CA) as per manufacturer's 
instructions. β-actin was used as the loading control. 
The density of protein bands was quantified using 
ImageJ software.  
Zebrafish tumor transplantation model. The 
study was performed as per the protocol approved by 
the Institutional Animal Care and Use Committee 
(IACUC) of Wayne State University (Protocol # A 
10-06-12). The pigment mutant (Casper) strains of 
Zebrafish (Danio rerio) were raised, staged, and 
maintained according to standard procedures. A 
published protocol was followed for tumor 
transplantation (Drabsch et al., 2013). Briefly, 
dechorionated 2 days-post fertilization (dpf) 
zebrafish embryos were anesthetized with 0.003% 
tricaine (Sigma-Aldrich, St. Louis, Mo) and 
positioned in a 10-cm Petri dish coated with 3% 
agarose (see Supporting Information, Figure 1S for a 
schematic representation of the in vivo protocol). 
Tumor cells were labeled with the fluorescent cell 
tracker CM-DiI (Invitrogen, Waltham, MA) 
following standard protocol and suspended in PBS 
containing 25 µM glucose and 0.2% gelatin. The cell 
suspension was loaded into borosilicate glass 
capillary needles (1 mm O.D. × 0.78 mm I.D.; 
Harvard Apparatus) and the injections were 
performed using a Picolitre Injector and a 
manipulator (Harvard Apparatus, Holliston, MA). 
Approximately 200 cells were implanted into the 
yolk sac in 13.2 nl volume. After implantation with 
mammalian cells, zebrafish embryos (including 
PBS-injected controls) were maintained at 33°C. 
Two to four hours after tumor implantation, the 
embryos were divided into experimental groups and 
‘seeded’ by placing 10 embryos/well into a 6-well 
plate in 4 ml E3 water. Plant extract (SocL) was 
added into the water at various doses, as indicated. 
After further incubating for 4 days, the embryos were 
euthanized with 0.03% tricaine, fixed with 4% PFA 
and whole mounted on a slide for imaging via 
confocal microscopy (Zeiss LSM 780). 
Quantification of fluorescence was performed in 
ImageJ. Images were imported and a threshold image 
was created from the red color channel. A total pixel 
count within the yolk sac or outside the yolk sac, 
including in the brain (metastasis) was enumerated 
using the measuring functionality within ImageJ. 
Values from single cells imaged at the same 
resolution (approximately 5-pixel count 
corresponded to one cell volume) were used to 
estimate the number of tumor cells at the injection 
site (yolk sac) and in the brain area. 
Wound-healing/ Scratch assay. Cells were 
seeded in 12-well plates (2.5 x 105 cells/well) and 
incubated in DMEM/F12 containing 10% FBS for 
24-48 h, until approximately 80% confluency. Cells 
were then linearly scratched with the tip of a 200 µL 
pipette and subsequently incubated with different 
doses of SocL extract. Images were captured under a 
microscope (Olympus) using QCapture Pro 
(Teledyne QImaging) at various time points, as 
indicated. Images were analyzed using ImageJ (NIH, 
Bethesda, MD).  
Statistical analysis. All the experiments were 
performed three times with at least two different 
NSCLC cell types. Statistical significance was 
determined using one-way ANOVA followed by a 
post hoc t-test to compare pairs of samples. A ‘p’ 
value of less than 0.05 was considered significant.  
RESULTS 
First, we examined the dose-dependent effect of 
SocL extract on the proliferation and apoptosis of 
lung cancer cells. Two NSCLC cell lines, A-549 and 
NCI-H358, as well as two patient-derived, brain-
metastatic lung cancer cells 18-032 and 18-033, were 
cultured for 72 h in the presence of various doses of 
SocL extract or flavonoid wogonin. As analyzed via 
WST-1 assay, SocL extract dose-dependently 
Wright et al.: Scutellaria Extract Inhibits Proliferation and Migration of Brain
 35 
inhibited the proliferation/viability of all NSCLC 
cells tested, with 50% inhibition of proliferation 
(IC50) at a dose of approximately 150 μg/ml (Fig. 
1A).  
Figure 1. SocL inhibits proliferation and enhances apoptosis 
in non-small cell lung cancer (NSCLC) cells. Two NSCLC 
cell lines (A549 and H358) and two patient-derived, brain 
metastatic NSCLC cells (18-032 and 18-033) were cultured 
with various doses of SocL extract, as indicated. (A)  After 
72 hours of culture, a WST-1 assay was performed to 
estimate cell proliferation/viability as described under the 
Methods. WST-1 assay was performed in triplicates with 
three repeats (B) After 48 hours of culture, cells were stained 
with Annexin-V and PI then analyzed by flow cytometry. 
Apoptosis data (dot plots) are representative of two different 
experiments performed in duplicates (n=4) with two 
different NSCLC cells with similar results. *p<0.05 versus 
media controls. 
SocL extract has previously been characterized 
by HPLC for the presence of 6 major flavonoids 
(apigenin, baicalein, baicalin, chrysin, scutellarein 
and wogonin) and only wogonin was detectable in 
trace amounts (0.1 µg/mg extract) (Parajuli et al., 
2009). Similar to the crude SocL extract, wogonin 
also dose-dependently inhibited the proliferation of 
H358 and 18-032 cells, with an IC50 value at 
approximately 50 µM dose (Supporting Information, 
Figure 2S). 
Cells (NSCLC) were similarly cultured with 
various doses of SocL extract for 48 h and induction 
of apoptosis was analyzed as described in the 
methods section. SocL extract dose-dependently 
enhanced the frequency of early apoptotic cells 
(25.7% and 35.1% Annexin-V positive cells at doses 
100- and 200 μg/ml, respectively) compared to the 
controls (18.6%) (Fig. 1B, representative results 
from 18-032 cells). Similar results were obtained 
with H358 cells (data not shown). 
To explore possible mechanisms associated with 
the inhibition of proliferation and promotion of 
apoptosis, NSCLC cells were cultured with various 
doses of SocL extract for 48 h, and intracellular 
signaling activity was analyzed via western blot 
assay as described under the methods section. We 
observed baseline constitutive activation 
(phosphorylation) of Akt (PI3 kinase) and p44/42 
(MAPK) pathways in all NSCLC cells tested. 
Representative data of 18-032 cells is shown in Fig. 
2. There was a dose-dependent inhibition of 
phosphorylated Akt and p44/42 following treatment 
with SocL extract (Fig. 2A and 2B). On the other 
hand, phosphorylation of p38 was dose-dependently 
enhanced following treatment with SocL extract 
(Fig. 2C). 
Figure 2. Modulation of various cell signaling pathways by 
SocL in NSCLC cells. NSCLC cells were cultured with 
various doses of SocL extract, as indicated. After 48 hours, 
cells were lysed, electrophoresed and analyzed by western 
blot assay, as described in the Methods section. Images for 
phosphorylated and non-phosphorylated proteins for (A) 
Akt, (B) p44/42 ERK and (C) p38 MAPK, as well as 
corresponding b-actin images, were quantitated by ImageJ 
software to obtain densitometric values. Histogram plots 
represent data for phosphorylated proteins, which are 
normalized against values for β-actin. *p<0.05 versus media 
controls. Data are mean ± SD of three different experiments. 
(A) *p = 0.035; **p = 0.011; (B) **p = 0.009; (C) **p = 
0.032. 
The expression of apoptosis-regulating proteins 
Bcl-2 and Bcl-xL were also analyzed under similar 
conditions. We observed dose-dependent inhibition 
of both Bcl-2 and Bcl-xL by SocL extract (Fig. 3). 
However,  only inhibition of Bcl-xL (approximately 
40% and 60% inhibition by SocL at doses 100- and 
200 μg/ml, respectively) was statistically significant 
(Fig. 3). 




Figure 3. Modulation of apoptosis-regulating proteins by 
SocL in NSCLC cells. NSCLC cells were cultured with 
various doses of SocL extract, as indicated. After 48 hours, 
cells were lysed, electrophoresed and analyzed by western 
blot assay, as described in the Methods section. Images for 
expression of (A) Bcl-2 and (B) Bcl-xL proteins were 
quantitated by ImageJ software to obtain densitometric 
values. Histogram plots represent data for (A) Bcl-2 and (B) 
Bcl-xL proteins, which are normalized against 
corresponding values for β-actin. Data are mean ± SD of 
three different experiments. (B) *p = 0.034; **p = 0.015 
 
 
In our previous study, SocL upregulated the 
activation of p38 MAPK in glioma cells (Dandawate 
et al., 2012). Data shown in Fig. 2C also displayed 
similar dose-dependent increase in p38 activation by 
SocL in lung cancer cells. We, therefore, wanted to 
further examine whether the activation of p38 played 
a role in the inhibition of proliferation and induction 
of apoptosis by SocL. As shown in Fig. 4A, NSCLC 
cells treated with SocL showed an expected decrease 
in proliferation, which was dose-dependently 
reversed by the specific p38 inhibitor (SB 202190, 
Sigma-Aldrich). Similarly, SocL-induced apoptosis 
was also significantly reversed by SB202190 
(21.14% versus 33.37% in the SocL group) (Fig. 4B). 
These results indicated that SocL-mediated 
enhancement of p38 activation is partially involved 
in the inhibition of proliferation and induction of 
apoptosis in NSCLC cells.  
 
 
Figure 4. Inhibition of proliferation and induction of 
apoptosis by SocL is partially mediated via modulation of 
p38 MAPK signaling. The patient-derived, brain metastatic 
NSCLC cells (18-032 and 18-033) were cultured with SocL 
extract in the presence of various doses of specific p38 
inhibitor SB 202190, as indicated. (A)  After 72 hours of 
culture, a WST-1 assay was performed to estimate cell 
proliferation/viability as described under the methods. Data 
are mean ± SD of one experiment (n=3), out of two 
performed with similar results. *p = 0.024; **p = 0.017. (B) 
After 48 hours of culture, cells were stained with Annexin-
V and PI then analyzed by flow cytometry to estimate the 
induction of apoptosis. Apoptosis data (dot plots) are 
representative of two different experiments performed with 
18-032 cells. Experiments were repeated with 18-033 cells 
with similar results.  
Finally, inhibition of migration and metastasis of 
NSCLC cells by SocL extract were examined in vitro 
and in vivo, along with any modulation in 
MMP2/MMP9 expression. A zebrafish model was 
utilized to examine the effects of SocL in vivo, as 
described in the methods section. Briefly, zebrafish 
embryos were inoculated with approximately 200 
DiI (red fluorescent) -tagged H358 cells into the yolk 
sacs, then treated with SocL extract (200 μg/ml in E3 
water) or E3 water alone (control). The zebrafish 
embryos were further incubated for 96 h, euthanized, 
and then imaged under a confocal microscope. The 
proliferation of injected NSCLC cells, as well as 
noticeable cell migration to the brain, was observed 
in the control group (Fig. 5). On the other hand, SocL 
treated zebrafish embryos had significantly lower 
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cell volume in the yolk sac while migration into the 
brain area was not noticeable (Fig. 5). 
 
Figure 5. Inhibition of brain metastasis of NSCLC cells by 
SocL in a zebrafish model. A zebrafish model of brain 
metastatic NSCLC was developed, as described in the 
Methods section. Briefly, metastatic NSCLC (H358) cells 
were labeled with a red fluorescent dye (Dil) and 
approximately 200 cells were nano-injected into the yolk 
sacs of 48 hpf zebrafish embryos. The embryos were then 
incubated in E3 water containing SocL extract, as indicated. 
After 72 hours, images were taken under a confocal 
microscope. The images were analyzed by Zen Lite software 
and the red fluorescence intensity (pixels as a measure of cell 
volume) was quantitated using ImageJ. Data are mean ± SD 
of one experiment (n=10), out of two performed with similar 
results. *p = 0.009; **p = 0.001. 
To further test what effects SocL has on cell 
migration, a scratch assay was performed as 
described in the Methods section. Images were taken 
before and after treatment to record the progression 
of wound-healing. We observed that control wells 
displayed widespread cell migration, with cells 
interspersed within the initial scratch (Fig. 6). SocL 
treated wells showed a marked decrease in migration, 
and in the case of 200 μg/ml, a slight digression 
occurred as measured by a comparison of the area of 
the scratch before and after treatment, indicating 
inhibition of cell survival/proliferation by SocL 
extract (Fig. 6). The results display a clear dose-
dependent inhibition of migration or pro-metastatic 
behavior of NSCLC cells by SocL extract. 
Matrix-metallopeptidases (MMPs) contribute 
greatly to both migration and metastasis, with 
metastatic cancer cells producing elevated levels of 
MMPs (Gialeli, Theocharis et al. 2011). 
 
Figure 6. Inhibition of in vitro migration of NSCLC cells by 
SocL extract. NSCLC cells were plated in 12 well plates and 
a scratch/wound-healing assay was performed, as described 
in the Methods section. Briefly, a straight-line 
scratch/wound was made in the middle of the semi-confluent 
monolayer of cells. The cells were cultured with various 
doses of SocL, as indicated, for 72 hours. Images were taken 
before treatment (day 0), as well as after 72 hours (day 3). 
The scratch areas were quantitated using ImageJ software. 
The histogram plot represents the scratch area on day 3 as a 
% value of the exact same scratch on day 0. Data are mean 
± SD of one experiment (n=3), out of two performed with 




Figure 7. Modulation of migration/metastasis-regulating 
proteins by SocL in NSCLC cells. NSCLC cells were 
cultured with various doses of SocL extract, as indicated. 
After 48 hours, cells were lysed, electrophoresed and 
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analyzed by western blot assay, as described in the Methods 
section. Images for expression of (A) MMP2 and (B) MMP9 
proteins were quantitated by ImageJ software to obtain 
densitometric values. Histogram plots represent data for (A) 
MMP2 and (B) MMP9 proteins, which are normalized 
against corresponding values for β-actin. Data are mean ± 
SD of three different experiments. (A) *p = 0.04; **p = 
0.017; (B) **p = 0.034. 
 We observed a significant, dose-dependent 
inhibition of MMP2 expression in NSCLC cells 
following treatment with SocL (40% and 60% 
inhibition with SocL at 100- and 200 μg/ml, 
respectively), compared to the control group (Fig. 
7A). On the other hand, the greatest drop (45% 
inhibition compared to control) in MMP9 expression 
was observed in the higher, 200 μg/ml dose group, 
while the lower, 100 ug/ml dose showed negligible 
effects on MMP9 expression (Fig. 7B).  
DISCUSSION 
Scutellaria is a member of the mint family which 
has been featured prominently in traditional Chinese 
medicine (TCM) as well as in Native American folk 
medicine. Various species of Scutellaria have 
reported usage for a myriad of ailments including 
inflammatory disorders, anxiety, and cancer (Patel et 
al., 2013; Wright and Parajuli, 2019). Our group has 
previously reported anti-cancer activities of leaf, 
root, and stem extracts derived from 13 different 
species of Scutellaria using in vitro models of breast 
cancer, prostate cancer, and brain cancer (glioma) 
cells, from which Scutellaria ocmulgee Leaf (SocL) 
extract, containing trace amounts of wogonin, was 
selected to be the one with most anti-cancer activities 
(Parajuli et al., 2009). Subsequent work in our lab has 
used in vitro and in vivo syngeneic models of 
malignant gliomas and showed that apart from 
directly interfering with tumor survival and apoptotic 
pathways in cancer, SocL extracts can modulate the 
stromal immune component by affecting the TGF-β1 
pathway (Parajuli et al., 2011; Dandawate et al., 
2012). 
 Our results indicated that SocL extract could 
inhibit proliferation, induce apoptosis and inhibit 
migration/invasion of metastatic lung cancer cells 
involving the modulation of Akt, P44/42, and p38 
signaling pathways. Scutellaria barbata extracts 
have been shown to inhibit metastasis/migration of 
colorectal cancer cells, likely via targeting the two 
signaling pathways PI3 kinase/Akt and TGF-
β/Smad3 (Jin et al., 2017). One of the Scutellaria 
flavonoids, baicalin has recently been shown to 
inhibit invasion, migration, and metastasis of breast 
cancer cells via modulation of p38 MAPK activity 
(Xiu- Feng et al., 2013). In another recent study, 
Scutellaria barbata extract inhibited proliferation, 
induced autophagy, and apoptosis in CL1-5 Lung 
cancer cells via inhibition of p38 MAPK signaling 
(Chen et al., 2017). Baicalein has been reported to 
induce apoptosis in FRO thyroid cancer cells via 
upregulation of P38 and modulation of AKT 
pathways (Han et al., 2019). The results of these 
studies agree with the results of our studies on SocL 
extract. Our previous studies have also shown in 
vitro and in vivo anti-tumor activity of SocL extract 
via modulation of Akt/GSK-3b and p44/42 ERK 
signaling in malignant glioma cells (Parajuli et al., 
2009, Parajuli et al., 2011). As reported earlier, 
wogonin was detected in SocL extract only in very 
small amounts (0.1 µg/mg extract), which does not 
correlate with the cytotoxic activity of the extract. 
This suggests that wogonin has synergistic activity 
with other phytochemicals in the extract which are 
yet to be identified. Our group has been working on 
further identifying the active components in the 
extract via HPLC/MS fractionation and in vitro 
characterization. 
Protein Kinase B, also known as Akt, can play an 
important role in modulating proliferation, apoptosis 
as well as metastatic behavior of cancer cells 
(Cheung and Testa, 2013). Constitutive activation of 
the Akt pathway is common in many cancers and can 
result in uncontrollable cell proliferation and 
migration (Tian et al., 2018). Inhibition of Akt 
combined with activation of p38 MAPK, as observed 
in the current study, is associated with the anti-
proliferative and pro-apoptotic activity (Berra et al., 
1998). 
P44/42, also known as extracellular signal-
regulated kinase 1/2 (ERK1/2), is known to promote 
cellular proliferation and is a common pathway 
upregulated in various cancers (Rodriguez-
Berriguete et al., 2012). P44/42 MAPK might also 
play a role in the production of MMP2. In a study 
identifying the role of MMP2 in brain metastatic 
breast cancer, higher levels of Erk1/2 activation were 
found to correlate with heightened levels of MMP2 
(Mendes et al., 2007). The dose-dependent inhibition 
of both MMP2 and P44/42 activation by SocL, as 
observed in the current study, could be explained by 
an analogous mechanism, though more investigation 
is needed to formulate a concrete link. 
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P38 MAP kinase is a stress response protein 
associated with promoting apoptosis in certain cell 
types via inhibition of Bcl-2 (Cai et al., 2006). In fact 
p38 MAPK signaling can have either agonistic or 
antagonistic effect on tumor cell survival, 
proliferation or migration, depending on the tumor 
type and interaction with other signaling activities. 
Therefore, the tumor type and context of signaling 
activities should be carefully considered while 
designing therapeutic strategies targeting the 
intracellular signaling pathways. In our previous 
study, SocL and flavonoids found in SocL had been 
associated with an increase in the phosphorylation of 
p38 (Dandawate et al., 2012). The Bcl-2 and its 
family members are associated with anti-apoptotic 
effects and are commonly upregulated in many 
cancers (Frenzel et al., 2009). Although in the current 
study, the modulation of BCL-2 by SocL was very 
marginal, a significant decrease in BCL-xL was 
observed in NSCLC cells, providing insight on how 
apoptosis might be regulated after SocL treatment.  
We have previously reported in vivo activity of 
SocL extract against malignant gliomas without 
apparent toxicity at a peroral dose of 250 mg/kg 
(Parajuli et al., 2011). Some clinical studies have 
shown promising signs for other species of 
Scutellaria in cancer treatment applications. In a 
phase 1b dose-escalation clinical trial, in patients 
with metastatic breast cancer, treatment with 
Scutellaria barbata displayed encouraging safety 
and efficacy (Perez et al., 2010). Lin et al. (2019) 
have recently published a retrospective study 
evaluating the risk of lung cancer development in 
more than 34,000 patients with chronic obstructive 
pulmonary disease (COPD) among users (11,180) 
and non-users (23,319) of Chinese herbal medicine 
(CHM), of which Scutellaria was one of the top 10 
components. The result indicated that patients with 
COPD who used CHM in combination with 
conventional therapies had a significantly lower risk 
of lung cancer development compared to the patients 
not using CHM (Lin et al., 2019). 
Treatment for lung cancer can vary depending on 
type and stage but most include the typical chemo- 
and radiation therapies. Many of these treatments, 
especially platinum-based therapies, are also 
associated with known adverse side effects. 
Moreover, survival rates substantially decrease once 
metastasis has occurred (Poullis et al., 2014). 
Therefore, any non-deleterious treatment with anti-
metastatic activity could potentially improve the 
survival rate in these patients.  
Finally, few studies have focused on the direct 
effects of Scutellaria on metastasis. Gong et al. 
(2014) investigated the effects of flavonoids baicalin, 
baicalein and wogonin found in Scutellaria 
baicalensis on lung cancer metastasis, proliferation, 
and inflammation induced by nicotine. The results 
were very promising. Zheng et al. (2018) studied the 
effects of Scutellaria barbata on bone metastatic 
breast cancer and have reported inhibition of 
metastasis and cell viability via modulation of 
RANKL (Zheng et al., 2018). We have observed a 
dose-dependent inhibition of metastatic behavior of 
brain metastatic NSCLC both in vitro and in a 
zebrafish model by direct treatment with SocL. The 
results indicate a promise for Scutellaria ocmulgee 
as a potential anti-metastatic agent that could be used 
in future combination therapy.  
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